Screening of Septo-optic Dysplasia During a Fetal Examinatio... | Clinical Trial | StuddyBuddy@endsection
← Back to all trials
Completed
NCT05717855
Screening of Septo-optic Dysplasia During a Fetal Examination at 16-20 Weeks of Gestation
Conditions: 2D Ultrasound, Cavum Septum Pellucidum, Septooptic Dysplasia, Optic Chiasma, Willis Polygon
Sex: Female
Ages: 18 Years – N/A
Healthy volunteers: 1
Phase: NA
Enrollment: 52
Sponsor: Gaziosmanpasa Research and Education Hospital
Location: Turkey
Summary
Evaluation of prenatal optic chiasm (OC) is important for the differential diagnosis of septo-optic dysplasia (SOD), which is a congenital optic disc anomaly, and the absence of the cavum septum pellucidum (CSP).
Septo-optic dysplasia is associated with a wide range of neurological abnormalities, including hypoplasia of the visual pathways, CSP agenesis, and developmental delay.
Eligibility Criteria
Inclusion Criteria:aged greater than 18 years oldhaving singleton pregnancyExclusion Criteria:being under the age of 18having IVF pregnancyhaving multiple pregnancycomorbidity during pregnancysmoking historypresence of familial genetic disease
Source: ClinicalTrials.gov (NCT05717855). StuddyBuddy aggregates publicly available trial information.